Skip to content

Medical-device intelligence

NQZ: Antigen, Invasive Fungal Pathogens

FDA product code NQZ: Antigen, Invasive Fungal Pathogens. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NQZ
FDA device name
Antigen, Invasive Fungal Pathogens
Device class
2
Regulation number
866.3050
Medical specialty
Microbiology
Review panel
MI

FDA definition

Invasive fungal pathogen assays are devices that consist of antigens, antisera, or proteases used in serological assays for the presumptive diagnosis of fungal infection in serum or plasma. The assay is indicated for use in patients with symptoms of, or medical conditions predisposing the patient to invasive fungal infection. The device can be used as an aid in the diagnosis of deep seated mycoses and fungemias. A positive result does not indicate which class of fungi may be causing infection. The assays should be used in conjunction with other diagnostic procedures, such as microbiological culture, histological examination of biopsy samples and radiological examination.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

1 clearance records and 2 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Dec 19, 2018 to Aug 17, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NQZ · Antigen, Invasive Fungal Pathogens12

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
Fungitell STAT- IVD Assay for (1 3)-~-D-Glucan in Serum Ref: FT007Z-1774-2022 · NQZAssociates of Cape Cod, Inc.RecallSep 20, 2022FDA record creation date
Fungitell STATK191167 · NQZAssociates of Cape Cod, Inc.510(k)Jul 17, 2019FDA decision date
Fungitell Kit, Catalog FT001 - Product Usage: The Fungitell assay is a potease zymogen-based colorimetric assay for the qualitative detection of …Z-1329-2019 · NQZAssociates of Cape Cod, Inc.RecallMay 14, 2019FDA record creation date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗